Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.26B | 14.66B | 15.67B | 13.68B | 12.25B | Gross Profit |
8.17B | 7.41B | 7.68B | 7.67B | 7.15B | EBIT |
2.67B | 3.20B | 2.62B | 2.83B | 2.65B | EBITDA |
5.48B | 6.06B | 5.03B | 4.72B | 4.37B | Net Income Common Stockholders |
1.82B | 2.52B | 1.66B | 1.35B | 1.10B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.32B | 1.19B | 1.28B | 992.00M | 1.27B | Total Assets |
70.56B | 66.33B | 69.06B | 63.12B | 62.90B | Total Debt |
27.82B | 25.01B | 24.41B | 25.36B | 25.08B | Net Debt |
26.50B | 23.82B | 23.13B | 24.37B | 23.81B | Total Liabilities |
48.60B | 45.17B | 48.18B | 42.78B | 43.83B | Stockholders Equity |
21.96B | 21.16B | 20.69B | 20.04B | 18.85B |
Cash Flow | Free Cash Flow | |||
-1.16B | -2.34B | -233.00M | -1.22B | -1.71B | Operating Cash Flow |
3.61B | 2.16B | 3.94B | 2.73B | 2.20B | Investing Cash Flow |
-5.27B | -1.00B | -4.57B | -3.48B | -4.22B | Financing Cash Flow |
1.80B | -1.49B | 1.01B | 461.00M | 2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $35.02B | 21.21 | 12.96% | 3.15% | 4.42% | 11.98% | |
70 Outperform | $37.21B | 15.57 | 8.55% | 0.41% | 1.91% | -4.40% | |
70 Neutral | $40.98B | 20.90 | 10.26% | 3.15% | -0.44% | 2.14% | |
68 Neutral | $39.64B | 20.31 | 8.33% | 3.10% | 8.52% | 3.91% | |
68 Neutral | $36.15B | 27.38 | 8.96% | 2.80% | -0.84% | -37.59% | |
65 Neutral | $39.77B | 21.42 | 11.40% | 3.06% | 11.24% | 1.15% | |
63 Neutral | $8.48B | 10.79 | 5.35% | 4.36% | 3.55% | -11.17% |